KDM2B
Basic information
Region (hg38): 12:121429096-121582279
Previous symbols: [ "FBXL10" ]
Links
Transcripts
Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 4 of 71.
| Transcript ID | Protein ID | Coding exons | MANE Select | MANE Plus Clinical |
|---|---|---|---|---|
ENST00000377069.8 | ENSP00000366269.3 | 23 | - | - |
ENST00000377071.9 | ENSP00000366271.3 | 23 | yes | - |
ENST00000446152.6 | ENSP00000398279.2 | 11 | - | - |
ENST00000538046.6 | ENSP00000474307.1 | 10 | - | - |
Phenotypes
GenCC
Source:
- neurodevelopmental disorder (Moderate), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (142 variants)
- not_provided (117 variants)
- KDM2B-related_disorder (39 variants)
- NEURODEVELOPMENTAL_DISORDER_WITH_CONGENITAL_CARDIAC_DEFECTS_AND_VARIABLE_RENAL_AND_OCULAR_ABNORMALITIES (8 variants)
- not_specified (3 variants)
- Neurodevelopmental_disorder (1 variants)
- KDM2B-related_syndrome (1 variants)
- Global_developmental_delay (1 variants)
- Infantile_spasms (1 variants)
- Microcephaly (1 variants)
- Hypotonia (1 variants)
- Severe_combined_immunodeficiency_disease (1 variants)
- KDM2B_Gene_Mutation (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KDM2B gene is commonly pathogenic or not. These statistics are base on transcript: NM_000032590.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 21 | 6 | 31 | ||
| missense | 7 | 7 | 210 | 12 | 236 | |
| nonsense | 7 | 7 | ||||
| start loss | 0 | |||||
| frameshift | 2 | 2 | 5 | 1 | 10 | |
| splice donor/acceptor (+/-2bp) | 1 | 7 | 8 | |||
| Total | 9 | 10 | 233 | 34 | 6 |
Highest pathogenic variant AF is 6.8426226e-7
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| KDM2B | protein_coding | protein_coding | ENST00000377071 | 23 | 152021 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 124787 | 0 | 7 | 124794 | 0.0000280 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 3.44 | 573 | 856 | 0.669 | 0.0000575 | 8701 |
| Missense in Polyphen | 125 | 303.21 | 0.41225 | 2996 | ||
| Synonymous | 0.173 | 353 | 357 | 0.988 | 0.0000252 | 2589 |
| Loss of Function | 6.87 | 6 | 66.4 | 0.0904 | 0.00000337 | 735 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000290 | 0.0000290 |
| Ashkenazi Jewish | 0.000100 | 0.0000993 |
| East Asian | 0.0000556 | 0.0000556 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000362 | 0.0000265 |
| Middle Eastern | 0.0000556 | 0.0000556 |
| South Asian | 0.0000329 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Histone demethylase that demethylates 'Lys-4' and 'Lys- 36' of histone H3, thereby playing a central role in histone code. Preferentially demethylates trimethylated H3 'Lys-4' and dimethylated H3 'Lys-36' residue while it has weak or no activity for mono- and tri-methylated H3 'Lys-36'. Preferentially binds the transcribed region of ribosomal RNA and represses the transcription of ribosomal RNA genes which inhibits cell growth and proliferation. May also serve as a substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. {ECO:0000269|PubMed:16362057, ECO:0000269|PubMed:17994099}.;
- Pathway
- HDMs demethylate histones;Chromatin modifying enzymes;Chromatin organization
(Consensus)
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- loftool
- 0.628
- rvis_EVS
- -2.17
- rvis_percentile_EVS
- 1.42
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.624
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;spermatogenesis;midbrain-hindbrain boundary morphogenesis;fourth ventricle development;lateral ventricle development;third ventricle development;initiation of neural tube closure;positive regulation of cell growth;forebrain development;midbrain development;hindbrain development;histone H2A monoubiquitination;negative regulation of neuron apoptotic process;embryonic camera-type eye morphogenesis;oxidation-reduction process;histone H3-K36 demethylation;positive regulation of stem cell population maintenance;negative regulation of neural precursor cell proliferation
- Cellular component
- nucleus;nucleoplasm;nucleolus;PcG protein complex
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA binding;protein binding;zinc ion binding;rRNA binding;histone demethylase activity;histone demethylase activity (H3-K36 specific)